The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: Relationship to tumor grade and survival

Clinical Cancer Research

Volumn 9, Issue 9, 2003, Pages 3369-3375

  Zhou, Yi Hong ^a   Tan, Fang ^a   Hess, Kenneth R ^a   Yung, W K Alfred ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RNA DIRECTED DNA POLYMERASE; TRANSCRIPTION FACTOR PAX6; VASCULOTROPIN;

AGE; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME;

BRAIN NEOPLASMS; CELL LINE, TUMOR; DNA, COMPLEMENTARY; EYE PROTEINS; GLIOMA; HOMEODOMAIN PROTEINS; HUMANS; PAIRED BOX TRANSCRIPTION FACTORS; PHOSPHORIC MONOESTER HYDROLASES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0041333109     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. nd Ed., pp. 9-54. Lyon, France: IARC Press, 2000.
2. CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 1992-1997. Published by the Central Brain Tumor Registry of the United States, 2000.
3. Daumas-Duport, C., Scheithauer, B. W., O'Fallon, J. R., and Kelly, P. Grading of astrocytomas, a simple and reproducible method. Cancer (Phila.), 62: 2152-2165, 1988.
4. th Ed, pp. 600-47. London: Arnold, 1997.
5. Ransom, D. T., Ritland, S. R., Moertel, C. A., Dahl, R. J., O'Fallon, J. R., Scheithauer, B. W., Kimmel, D. W., Kelly, P. J., Olopade, O. I., Diaz, M. O., et al. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligoastrocytomas. Genes Chromosomes Cancer, 5: 357-374, 1992;
6. von Deimling, A., von Ammon, K., Schoenfeld, D., Wiestler, O. D., Seizinger, B. R., and Louis, D. N. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol., 3: 19-26, 1993.
7. Rasheed, B. K., Fuller, G. N., Friedman, A. H., Bigner, D. D., and Bigner, S. H. Loss of heterozygosity for 10q loci in human gliomas. Genes Chromosomes Cancer, 5: 75-82, 1992.
8. Kon, H., Sonoda, Y., Kumabe, T., Yoshimoto, T., Sekiya, T., and Murakami, Y. Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas. Oncogene, 16: 257-263, 1998.
9. Louis, D. N. A molecular genetic model of astrocytoma histopathology. Brain Pathol., 7: 755-764, 1997.
10. Rasheed, B. K., Wiltshire, R. N., Bigner, S. H., and Bigner, D. D. Molecular pathogenesis of malignant gliomas. Curr. Opin. Oncol., 11: 162-167, 1999.
11. Nozaki, M., Tada, M., Kobayashi, H., Zhang, C. L., Sawamura, Y., Abe, H., Ishii, N., and Van Meir, E. G. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. Neuro-oncol., 1: 124-137, 1999.
12. Sano, T., Lin, H., Chen, X., Langford, L. A., Koul, D., Bondy, M. L., Hess, K. R., Myers, J. N., Hong, Y. K., Yung, W. K., and Steck, P. A. Differential expression of PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res., 59: 1820-1824, 1999.
13. Goussia, A. C., Agnantis, N. J., Rao, J. S., and Kyritsis, A. P. Cytogenetic and molecular abnormalities in astrocytic gliomas (Review). Oncol. Rep., 7: 401-412, 2000.
14. Ke, L. D., Shi, Y. X., Im, S. A., Chen, X., and Yung, W. K. The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines. Clin. Cancer Res., 6: 2562-2572, 2000.
15. Takano, S., Yoshii, Y., Kondo, S., Suzuki, H., Maruno, T., Shirai, S., and Nose, T. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res., 56: 2185-2190, 1996.
16. Eppenberger, U., and Mueller, H. Growth factor receptors and their ligands. J. Neuro-Oncol., 22: 249-254, 1994.
17. Eley, G. D., Reiter, J. L., Pandita, A., Park, S., Jenkins, R. B., Maihle, N. J., and James, C. D. A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma. Neuro-oncol., 4: 86-94, 2002.
18. Ton, C. C., Hirvonen, H., Miwa, H., Weil, M. M., Monaghan, P., Jordan, T., van Heyningen, V., Hastie, N. D., Meijers-Heijboer, H., Drechsler, M., et al. Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region. Cell, 67: 1059-1074, 1991.
19. Mansouri, A., Hallonet, M., and Gruss, P. Pax genes and their roles in cell differentiation and development. Curr. Opin. Cell Biol., 8: 851-817, 1996.
20. Prosser, J., and van Heyningen, V. PAX6 mutations reviewed. Hum. Mutat., 11: 93-108, 1999.
21. Sisodiya, S. M., Free, S. L., Williamson, K. A., Mitchell, T. N., Willis, C., Stevens, J. M., Kendall, B. E., Shorvon, S. D., Hanson, I. M., Moore, A. T., and van Heyningen, V. PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans. Nat. Genet., 28: 214-216, 2001.
22. Sander, M., Neubuser, A., Kalamaras, J., Ee, H. C., Martin, G. R., and German, M. S. Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev., 11: 1662-1673, 1997.
23. Zhou, Y. H., Glass, T., Zheng, J. B., Yung, W. K. A., and Saunders, G. PAX6 function in the suppression pathway of gliomas. Neuro-Oncol., 2: 305, 2000.
24. Pershouse, M. A., Stubblefield, E., Hudi, A., Killary, A. M., Yung, W. K. A., and Steck, P. A. Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res., 53: 5043-5050, 1993.
25. Frederick, L., Wang, X. Y., Eley, G., and James, C. D. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res., 60: 1383-1387, 2000.
26. Teng, D. H., Hu, R., Lin, H., Davis, T., Iliev, D., Frye, C., Swedlund, B., Hansen, K. L., Vinson, V. L., Gumpper, K. L., Ellis, L., El-Naggar, A., Frazier, M., Jasser, S., Langford, L. A., Lee, J., Mills, G. B., Pershouse, M. A., Pollack, R. E., Tomos, C., Troncoso, P., Yung, W. K., Fujii, G., Berson, A., Steck, P. A., et al. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res., 57: 5221-5225, 1997.
27. Steck, P. A., Lin, H., Langford, L. A., Jasser, S. A., Koul, D., Yung, W. K., and Pershouse, M. A. Functional and molecular analyses of 10q deletions in human gliomas. Genes Chromosomes Cancer, 24: 135-143, 1999.
28. Ishii, N., Maier, D., Merlo, A., Tada, M., Sawamura, Y., Diserens, A. C., and Van Meir, E. G. Frequent co-alterations of TP53, p16/CDKN2A, pl4ARF. PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol., 9: 469-479, 1999.